DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Structural Biology & Molecular Modeling Techniques Market Analysis By Tools, By Application And Segment Forecasts 2014 - 2025" report to their offering.
The structural biology & molecular modeling techniques market is expected to reach USD 13.1 billion by 2025
An unprecedented rise in the adoption of unhealthy lifestyles has led to an upsurge in the prevalence of chronic diseases, such as diabetes and cancer, which is presumed to propel the structural biology & molecular modeling techniques market during the forecast period.
Moreover, increasing drug resistance coupled with the high drug attrition rate is engendering the requirement for extensive R&D activities, which is presumed to boost the adoption of structural biology & molecular modeling techniques in the drug discovery and development process. This is expected to serve as an efficient approach in fast tracking the development of drugs with high potency.
The heightening demand for molecular modeling techniques is predominantly attributable to the significant cost reduction enabled. This is due to the fact that prediction software identifies possible adverse reactions and determines drug efficacy and toxicity in the pre-clinical stages, thereby reducing the probability of drug failure at the later stages. Consequentially, the aforementioned factors serve as prominent reasons responsible for the widened market demand.
Companies Mentioned
- Dassault Systemes
- Agile Molecule
- Acellera Ltd.
- Bioinformatic LLC
- Affymetrix
- Agilent Technologies, Inc.
- Illumina
- Bruker Daltonics Inc.
- Biomax Informatics AG
- Chemical Computing Group
- CLC bio
For more information about this report visit http://www.researchandmarkets.com/research/fxhk2b/structural
